M.Sc. by Research in Biotherapeutics
A research-driven Master’s programme focused on biologic-based medicines made from biological sources, addressing the discovery and manufacture of modern biotherapeutic products.
M.Sc. by research in biotherapeutics overview
Biotherapeutics are biologic-based medicines used for the treatment of certain diseases. This programme is designed to build competencies aligned with the needs of industry and academia through structured coursework, laboratory exposure and extended research. The focus is on end-to-end discovery and manufacturing of biotherapeutic products. Students experience:
Biotherapeutic product focus
Exposure to biosimilars, vaccines, recombinant proteins, monoclonal antibodies, gene therapies, ADCs, siRNAs, mRNA drugs, CAR T-cell therapies and microbiomes.
Bioprocess and manufacturing training
Learning across upstream and downstream processing, continuous manufacturing, multi-product operations and green manufacturing practices.
Regulatory and analytical grounding
Coverage of compliance, regulatory affairs, pharmacovigilance, analytical characterisation and process analytical technology.
Research-intensive learning
One year of exclusive research focused on biotherapeutic discovery and manufacturing.
Programme details
Academic structure
Duration: 2 years / four semesters
Total credits: 80
| Course Code | Course Title | L–T–P | Credits |
|---|---|---|---|
| BT5120 | Introduction to Biotherapeutics and Techno-commercial Landscape | 2-0-0 | 2 |
| BT5121 | Biosimilars | 2-0-0 | 2 |
| BT5122 | Molecular Basis of Disease and Disease Models | 3-0-0 | 3 |
| BT5123 | Biotherapeutic Modalities | 3-0-2 | 4 |
| BT5124 | Bioprocess Technology: Upstream and Downstream | 3-0-2 | 4 |
| BT5125 | Biostatistics & Data Analysis | 2-0-2 | 3 |
| BT5126 | Biomanufacturing Biotherapeutics | 2-0-0 | 2 |
| Course Code | Course Title | L–T–P | Credits |
|---|---|---|---|
| BT5227 | Pharmacology and Toxicology | 3-0-2 | 4 |
| BT5228 | Biopharmaceutical Bioinformatics | 3-0-2 | 4 |
| BT5229 | Analytical & Functional Characterization of Biotherapeutics | 3-0-2 | 4 |
| BT5230 | Formulation Development and Delivery Systems | 3-0-0 | 3 |
| BT5231 | Quality, Regulatory Affairs & Compliance | 2-0-0 | 2 |
| BT5232 | Pharmacovigilance | 1-0-0 | 1 |
| BT5233 | Biotech Entrepreneurship and IPR Considerations | 2-0-0 | 2 |
| Course Code | Course Title | L–T–P | Credits |
|---|---|---|---|
| BT5334 | Research Project or Internship | 0-0-40 | 20 |
| Course Code | Course Title | L–T–P | Credits |
|---|---|---|---|
| BT5435 | Research Project or Internship | 0-0-40 | 20 |
Eligibility:
Qualifying Degree: B.Sc. (Biological Sciences/non-Medical) / B.Sc. (4-year program) / MBBS /BDS /B.Pharm./ B.Tech./ B.V.Sc.
Marks / CGPA / CPI in qualifying degree
- A minimum of 60% marks in aggregate, OR
- a first class as specified by the university, OR
- a minimum cumulative grade point average (CGPA) / cumulative performance index (CPI) of 6.0 on the scale of 0-10; OR
- an equivalent to 6.0 on other corresponding proportional requirements when the scales are other than 0-10.
Fee structure (per annum):
| Component | Amount |
|---|---|
| Academic fees (per annum) | ₹ 1,00,000 |
Competencies & Research Focus:
This programme builds industry-relevant competencies and research depth aligned with current and emerging needs in biotherapeutics, spanning manufacturing, analytics, regulation and advanced therapeutic platforms.
Competencies developed
| Area | Competencies |
|---|---|
| Biomanufacturing | Continuous manufacturing, upstream and downstream processing, multi-product operations |
| Quality & compliance | Compliance and regulatory affairs, pharmacovigilance integration |
| Sustainable practices | Green manufacturing |
| Process monitoring | Process analytical technology |
| Analytics | Analytical characterisation |
| Digital & technical skills | Computer-aided drug designing, technical report writing |
Research focus: biotherapeutic products
| Category | Focus areas |
|---|---|
| Biologics | Biosimilars, vaccines |
| Protein therapeutics | Recombinant proteins & peptides, monoclonal antibodies, bispecific antibodies (BsAb), nanobodies |
| Advanced modalities | Antibody–drug conjugates (ADCs), siRNAs, anti-sense oligonucleotides |
| Genetic & cell therapies | Gene therapy, CAR T-cell therapies |
| RNA & emerging platforms | mRNA drugs |
| Novel systems | Microbiomes |
FAQs
It focuses on discovery and manufacturing of biotherapeutic products through coursework, laboratory training and research.
The first two semesters focus on coursework, followed by two semesters dedicated to research or internship.
Students have access to specialised bioprocess, molecular biology, cell culture and computational biology laboratories.
The project-based framework encourages students to design creative engineering solutions while developing collaboration and leadership skills essential to the industry.
